Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Circ Heart Fail. 2021 Jul 1;14(7):e007849. doi: 10.1161/CIRCHEARTFAILURE.120.007849

Table 2.

Pathways that are differentially regulated between cases with hypertrophic cardiomyopathy and controls with hypertensive left ventricular hypertrophy

Pathway description Number of matching proteins Number of proteins in the pathway False discovery rate
Cytokine-cytokine receptor interaction 28 263 0.0000005
MAPK signaling pathway 26 293 0.00003
PI3K-Akt signaling pathway 28 348 0.00004
Ras signaling pathway 21 228 0.0001
Complement and coagulation cascades 10 78 0.004
Apoptosis 12 135 0.01
Focal adhesion 15 197 0.01
Chemokine signaling pathway 14 181 0.01
TNF signaling pathway 10 108 0.02
Proteasome 6 43 0.03
Rap1 signaling pathway 14 203 0.03
ECM-receptor interaction 8 81 0.03
ErbB signaling pathway 8 83 0.03
TGF-β signaling pathway 8 83 0.03
Fluid shear stress and atherosclerosis 10 133 0.04
JAK-STAT signaling pathway 11 160 0.04

ECM = extracellular matrix; JAK = Janus kinase; MAPK = mitogen-activated protein kinase; PI3K = phosphoinositide 3-kinase; STAT = signal transducer and activator of transcription; TGF = transforming growth factor; TNF = tumor necrosis factor